Delivery Order SPE2DR25D1100-SPE2DR26FCS9T
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, valued at $3,570.24, with an ultimate completion date of September 17, 2025. This non-set-aside contract employs firm fixed price pricing and represents a competitive award to a major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,494.25 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's pharmaceutical supply support to federal military and healthcare systems. The contract was executed under a non-set-aside procurement process, underscoring AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, valued at $2,884.33, with an ultimate completion date of November 10, 2025. This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, was issued on November 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of 36,000 units of Creon DR 100s capsules with a ceiling value of $4,655.89. This is a firm fixed price delivery order with no set-aside designation, demonstrating competitive award based on open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,424.24 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with an ultimate completion date of September 10, 2025. This competitively awarded contract, issued with firm fixed pricing and no set-aside designation, represents a continuation of pharmaceutical supply fulfillment from the vendor's established relationship with DLA. The delivery order is being performed at the company's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,306.74 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon in 100-count packages. This non-competitive, firm fixed-price delivery order was awarded on December 7, 2025, with an ultimate completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,117.97 to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s. This competitively awarded contract, which carries no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The firm fixed price delivery order will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,470.48 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of 24,000 unit capsules of Creon DR 100s, with a ceiling value of $8,755.73 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by August...
- The Defense Logistics Agency awarded a delivery order valued at $15,609.64 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and is performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS9TDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 24,000 unit capsules of Creon DR 100s, valued at $2,533.02, with a completion deadline of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The Creon DR capsules represent a specific therapeutic need within the DLA's broader pharmaceutical procurement strategy to maintain medical supply availability across defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/3/25 |